
### [MONDO:0000654](http://purl.obolibrary.org/obo/MONDO_0000654)
**Label:** connective tissue benign neoplasm

**Subclasses:** [MONDO:0008145](http://purl.obolibrary.org/obo/MONDO_0008145) (Ollier disease), [MONDO:0002119](http://purl.obolibrary.org/obo/MONDO_0002119) (ossifying fibroma (disease)), [MONDO:0001745](http://purl.obolibrary.org/obo/MONDO_0001745) (subserous uterine fibroid), [MONDO:0021477](http://purl.obolibrary.org/obo/MONDO_0021477) (benign neoplasm of sphenoidal sinus), [MONDO:0001664](http://purl.obolibrary.org/obo/MONDO_0001664) (submucous uterine fibroid), [MONDO:0003887](http://purl.obolibrary.org/obo/MONDO_0003887) (ovarian mucinous adenofibroma), [MONDO:0002359](http://purl.obolibrary.org/obo/MONDO_0002359) (juxtacortical chondroma), [MONDO:0004214](http://purl.obolibrary.org/obo/MONDO_0004214) (ovarian endometrioid cystadenofibroma), [MONDO:0004457](http://purl.obolibrary.org/obo/MONDO_0004457) (maxillary sinus Schneiderian papilloma), [MONDO:0007886](http://purl.obolibrary.org/obo/MONDO_0007886) (uterine corpus leiomyoma), [MONDO:0002399](http://purl.obolibrary.org/obo/MONDO_0002399) (nodular tenosynovitis), [MONDO:0006312](http://purl.obolibrary.org/obo/MONDO_0006312) (myofibroma), [MONDO:0010621](http://purl.obolibrary.org/obo/MONDO_0010621) (child syndrome), [MONDO:0002072](http://purl.obolibrary.org/obo/MONDO_0002072) (melanotic neuroectodermal tumor), [MONDO:0004705](http://purl.obolibrary.org/obo/MONDO_0004705) (liver fibroma), [MONDO:0009227](http://purl.obolibrary.org/obo/MONDO_0009227) (myofibromatosis, infantile, 1), [MONDO:0003458](http://purl.obolibrary.org/obo/MONDO_0003458) (uterine corpus adenofibroma), [MONDO:0004501](http://purl.obolibrary.org/obo/MONDO_0004501) (fallopian tube cystadenofibroma), [MONDO:0003695](http://purl.obolibrary.org/obo/MONDO_0003695) (ovarian clear cell adenofibroma), [MONDO:0003694](http://purl.obolibrary.org/obo/MONDO_0003694) (ovarian clear cell cystadenofibroma), [MONDO:0004384](http://purl.obolibrary.org/obo/MONDO_0004384) (maxillary sinus inverted papilloma), [MONDO:0004185](http://purl.obolibrary.org/obo/MONDO_0004185) (ovarian serous cystadenofibroma), [MONDO:0018936](http://purl.obolibrary.org/obo/MONDO_0018936) (osteoblastoma (disease)), [MONDO:0011744](http://purl.obolibrary.org/obo/MONDO_0011744) (primary intraosseous venous malformation), [MONDO:0018447](http://purl.obolibrary.org/obo/MONDO_0018447) (chondromyxoid fibroma), [MONDO:0014122](http://purl.obolibrary.org/obo/MONDO_0014122) (myofibromatosis, infantile, 2), [MONDO:0021531](http://purl.obolibrary.org/obo/MONDO_0021531) (fibroma of lung), [MONDO:0000513](http://purl.obolibrary.org/obo/MONDO_0000513) (bone ameloblastoma), [MONDO:0008168](http://purl.obolibrary.org/obo/MONDO_0008168) (ovarian fibroma (disease)), [MONDO:0001845](http://purl.obolibrary.org/obo/MONDO_0001845) (uterine corpus lipoleiomyoma), [MONDO:0001844](http://purl.obolibrary.org/obo/MONDO_0001844) (uterine corpus myxoid leiomyoma), [MONDO:0003703](http://purl.obolibrary.org/obo/MONDO_0003703) (uterine corpus leiomyomatosis), [MONDO:0021532](http://purl.obolibrary.org/obo/MONDO_0021532) (fibroma of prostate), [MONDO:0000516](http://purl.obolibrary.org/obo/MONDO_0000516) (phalanx chondroma), [MONDO:0003704](http://purl.obolibrary.org/obo/MONDO_0003704) (uterine corpus diffuse leiomyomatosis), [MONDO:0001846](http://purl.obolibrary.org/obo/MONDO_0001846) (uterine corpus bizarre leiomyoma), [MONDO:0001841](http://purl.obolibrary.org/obo/MONDO_0001841) (uterine corpus epithelioid leiomyoma), [MONDO:0000631](http://purl.obolibrary.org/obo/MONDO_0000631) (bone benign neoplasm), [MONDO:0003702](http://purl.obolibrary.org/obo/MONDO_0003702) (uterus intravascular leiomyomatosis), [MONDO:0004997](http://purl.obolibrary.org/obo/MONDO_0004997) (chondroblastoma (disease)), [MONDO:0001843](http://purl.obolibrary.org/obo/MONDO_0001843) (uterus interstitial leiomyoma), [MONDO:0001842](http://purl.obolibrary.org/obo/MONDO_0001842) (uterine corpus dissecting leiomyoma), [MONDO:0003980](http://purl.obolibrary.org/obo/MONDO_0003980) (schwannoma of jugular foramen), [MONDO:0004076](http://purl.obolibrary.org/obo/MONDO_0004076) (tendon sheath lipoma), [MONDO:0003461](http://purl.obolibrary.org/obo/MONDO_0003461) (fallopian tube adenofibroma), [MONDO:0005166](http://purl.obolibrary.org/obo/MONDO_0005166) (osteoma (disease)), [MONDO:0004077](http://purl.obolibrary.org/obo/MONDO_0004077) (lumbosacral lipoma), [MONDO:0004074](http://purl.obolibrary.org/obo/MONDO_0004074) (ovarian mucinous cystadenofibroma), [MONDO:0007660](http://purl.obolibrary.org/obo/MONDO_0007660) (familial ossifying fibroma), [MONDO:0016824](http://purl.obolibrary.org/obo/MONDO_0016824) (myofibromatosis), [MONDO:0008154](http://purl.obolibrary.org/obo/MONDO_0008154) (osteomas of mandible), [MONDO:0021522](http://purl.obolibrary.org/obo/MONDO_0021522) (benign neoplasm of lower jaw bone), [MONDO:0004326](http://purl.obolibrary.org/obo/MONDO_0004326) (sphenoid sinus inverted papilloma), [MONDO:0004327](http://purl.obolibrary.org/obo/MONDO_0004327) (sphenoid sinus Schneiderian papilloma), [MONDO:0004006](http://purl.obolibrary.org/obo/MONDO_0004006) (rete ovarii cystadenofibroma), [MONDO:0009808](http://purl.obolibrary.org/obo/MONDO_0009808) (osteoid Osteoma (disease)), [MONDO:0021484](http://purl.obolibrary.org/obo/MONDO_0021484) (benign neoplasm of maxillary sinus), [MONDO:0002780](http://purl.obolibrary.org/obo/MONDO_0002780) (extraskeletal chondroma), [MONDO:0004162](http://purl.obolibrary.org/obo/MONDO_0004162) (uterine corpus cellular leiomyoma), [MONDO:0006340](http://purl.obolibrary.org/obo/MONDO_0006340) (ovarian serous adenofibroma), [MONDO:0004482](http://purl.obolibrary.org/obo/MONDO_0004482) (fibroosseous pseudotumor of digits), [MONDO:0004161](http://purl.obolibrary.org/obo/MONDO_0004161) (uterine corpus apoplectic leiomyoma), 

**Mapped go classes:** [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:0061056](http://purl.obolibrary.org/obo/GO_0061056) (sclerotome development), [GO:0035441](http://purl.obolibrary.org/obo/GO_0035441) (cell migration involved in vasculogenesis), [GO:0060123](http://purl.obolibrary.org/obo/GO_0060123) (regulation of growth hormone secretion), [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:0006284](http://purl.obolibrary.org/obo/GO_0006284) (base-excision repair), [GO:0033144](http://purl.obolibrary.org/obo/GO_0033144) (negative regulation of intracellular steroid hormone receptor signaling pathway), [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0007010](http://purl.obolibrary.org/obo/GO_0007010) (cytoskeleton organization), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0050793](http://purl.obolibrary.org/obo/GO_0050793) (regulation of developmental process), [GO:0032967](http://purl.obolibrary.org/obo/GO_0032967) (positive regulation of collagen biosynthetic process), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0072223](http://purl.obolibrary.org/obo/GO_0072223) (metanephric glomerular mesangium development), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:2000491](http://purl.obolibrary.org/obo/GO_2000491) (positive regulation of hepatic stellate cell activation), [GO:0035793](http://purl.obolibrary.org/obo/GO_0035793) (positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0030261](http://purl.obolibrary.org/obo/GO_0030261) (chromosome condensation), [GO:0035791](http://purl.obolibrary.org/obo/GO_0035791) (platelet-derived growth factor receptor-beta signaling pathway), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0000228](http://purl.obolibrary.org/obo/GO_0000228) (nuclear chromosome), [GO:0006696](http://purl.obolibrary.org/obo/GO_0006696) (ergosterol biosynthetic process), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0040008](http://purl.obolibrary.org/obo/GO_0040008) (regulation of growth), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0003854](http://purl.obolibrary.org/obo/GO_0003854) (3-beta-hydroxy-delta5-steroid dehydrogenase activity), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0032956](http://purl.obolibrary.org/obo/GO_0032956) (regulation of actin cytoskeleton organization), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:2000648](http://purl.obolibrary.org/obo/GO_2000648) (positive regulation of stem cell proliferation), [GO:0035789](http://purl.obolibrary.org/obo/GO_0035789) (metanephric mesenchymal cell migration), [GO:0031226](http://purl.obolibrary.org/obo/GO_0031226) (intrinsic component of plasma membrane), [GO:0016126](http://purl.obolibrary.org/obo/GO_0016126) (sterol biosynthetic process), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0035025](http://purl.obolibrary.org/obo/GO_0035025) (positive regulation of Rho protein signal transduction), [GO:0090276](http://purl.obolibrary.org/obo/GO_0090276) (regulation of peptide hormone secretion), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0006024](http://purl.obolibrary.org/obo/GO_0006024) (glycosaminoglycan biosynthetic process), [GO:0021654](http://purl.obolibrary.org/obo/GO_0021654) (rhombomere boundary formation), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0060428](http://purl.obolibrary.org/obo/GO_0060428) (lung epithelium development), [GO:0048259](http://purl.obolibrary.org/obo/GO_0048259) (regulation of receptor-mediated endocytosis), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0038091](http://purl.obolibrary.org/obo/GO_0038091) (positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway), [GO:0048936](http://purl.obolibrary.org/obo/GO_0048936) (peripheral nervous system neuron axonogenesis), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis), [GO:0071670](http://purl.obolibrary.org/obo/GO_0071670) (smooth muscle cell chemotaxis), [GO:0050730](http://purl.obolibrary.org/obo/GO_0050730) (regulation of peptidyl-tyrosine phosphorylation), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0060947](http://purl.obolibrary.org/obo/GO_0060947) (cardiac vascular smooth muscle cell differentiation), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0035019](http://purl.obolibrary.org/obo/GO_0035019) (somatic stem cell population maintenance), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:2000773](http://purl.obolibrary.org/obo/GO_2000773) (negative regulation of cellular senescence), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0016616](http://purl.obolibrary.org/obo/GO_0016616) (oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0003680](http://purl.obolibrary.org/obo/GO_0003680) (AT DNA binding), [GO:0046488](http://purl.obolibrary.org/obo/GO_0046488) (phosphatidylinositol metabolic process), [GO:0038085](http://purl.obolibrary.org/obo/GO_0038085) (vascular endothelial growth factor binding), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0090280](http://purl.obolibrary.org/obo/GO_0090280) (positive regulation of calcium ion import), [GO:0001894](http://purl.obolibrary.org/obo/GO_0001894) (tissue homeostasis), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0098609](http://purl.obolibrary.org/obo/GO_0098609) (cell-cell adhesion), [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0048712](http://purl.obolibrary.org/obo/GO_0048712) (negative regulation of astrocyte differentiation), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0021514](http://purl.obolibrary.org/obo/GO_0021514) (ventral spinal cord interneuron differentiation), [GO:0060842](http://purl.obolibrary.org/obo/GO_0060842) (arterial endothelial cell differentiation), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0051321](http://purl.obolibrary.org/obo/GO_0051321) (meiotic cell cycle), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0072262](http://purl.obolibrary.org/obo/GO_0072262) (metanephric glomerular mesangial cell proliferation involved in metanephros development), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0055003](http://purl.obolibrary.org/obo/GO_0055003) (cardiac myofibril assembly), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0035633](http://purl.obolibrary.org/obo/GO_0035633) (maintenance of permeability of blood-brain barrier), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development), [GO:0021865](http://purl.obolibrary.org/obo/GO_0021865) (symmetric radial glial cell division in forebrain), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0046426](http://purl.obolibrary.org/obo/GO_0046426) (negative regulation of JAK-STAT cascade), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0035907](http://purl.obolibrary.org/obo/GO_0035907) (dorsal aorta development), [GO:0035909](http://purl.obolibrary.org/obo/GO_0035909) (aorta morphogenesis), [GO:0032516](http://purl.obolibrary.org/obo/GO_0032516) (positive regulation of phosphoprotein phosphatase activity), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development), [GO:0006807](http://purl.obolibrary.org/obo/GO_0006807) (nitrogen compound metabolic process), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0001878](http://purl.obolibrary.org/obo/GO_0001878) (response to yeast), [GO:0010863](http://purl.obolibrary.org/obo/GO_0010863) (positive regulation of phospholipase C activity), [GO:0030178](http://purl.obolibrary.org/obo/GO_0030178) (negative regulation of Wnt signaling pathway), [GO:0050768](http://purl.obolibrary.org/obo/GO_0050768) (negative regulation of neurogenesis), [GO:0050921](http://purl.obolibrary.org/obo/GO_0050921) (positive regulation of chemotaxis), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:0060981](http://purl.obolibrary.org/obo/GO_0060981) (cell migration involved in coronary angiogenesis), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0097150](http://purl.obolibrary.org/obo/GO_0097150) (neuronal stem cell population maintenance), [GO:0060501](http://purl.obolibrary.org/obo/GO_0060501) (positive regulation of epithelial cell proliferation involved in lung morphogenesis), [GO:0005017](http://purl.obolibrary.org/obo/GO_0005017) (platelet-derived growth factor-activated receptor activity), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0001840](http://purl.obolibrary.org/obo/GO_0001840) (neural plate development), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0047012](http://purl.obolibrary.org/obo/GO_0047012) (sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0003906](http://purl.obolibrary.org/obo/GO_0003906) (DNA-(apurinic or apyrimidinic site) lyase activity), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0017124](http://purl.obolibrary.org/obo/GO_0017124) (SH3 domain binding), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0021846](http://purl.obolibrary.org/obo/GO_0021846) (cell proliferation in forebrain), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0060613](http://purl.obolibrary.org/obo/GO_0060613) (fat pad development), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0005811](http://purl.obolibrary.org/obo/GO_0005811) (lipid droplet), [GO:0005019](http://purl.obolibrary.org/obo/GO_0005019) (platelet-derived growth factor beta-receptor activity), [GO:0000252](http://purl.obolibrary.org/obo/GO_0000252) (C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0072277](http://purl.obolibrary.org/obo/GO_0072277) (metanephric glomerular capillary formation), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0071864](http://purl.obolibrary.org/obo/GO_0071864) (positive regulation of cell proliferation in bone marrow), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), [GO:0010564](http://purl.obolibrary.org/obo/GO_0010564) (regulation of cell cycle process), 

**Class expressions from DL-Learner:**

- Thing 54.70%
- [GO:0098727](http://purl.obolibrary.org/obo/GO_0098727) (maintenance of cell number) 50.93%
- [GO:0097150](http://purl.obolibrary.org/obo/GO_0097150) (neuronal stem cell population maintenance) 50.93%
- [GO:0071670](http://purl.obolibrary.org/obo/GO_0071670) (smooth muscle cell chemotaxis) 50.93%
- [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development) 50.93%
- [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye) 50.93%
- [GO:0060981](http://purl.obolibrary.org/obo/GO_0060981) (cell migration involved in coronary angiogenesis) 50.93%
- [GO:0060840](http://purl.obolibrary.org/obo/GO_0060840) (artery development) 50.93%
- [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development) 50.93%
- [GO:0060674](http://purl.obolibrary.org/obo/GO_0060674) (placenta blood vessel development) 50.93%
- [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth) 50.93%
- [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development) 50.93%
- [GO:0035907](http://purl.obolibrary.org/obo/GO_0035907) (dorsal aorta development) 50.93%
- [GO:0035904](http://purl.obolibrary.org/obo/GO_0035904) (aorta development) 50.93%
- [GO:0035789](http://purl.obolibrary.org/obo/GO_0035789) (metanephric mesenchymal cell migration) 50.93%


